Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
Explore the detailed record of transactions filed by Markvicka Taunia, Chief Operating Officer. Insider active across 1 company, notably Statera Biopharma, Inc.. Aggregated, 1 filings have been recorded. History available since 28 September 2021. The latest transaction was disclosed on 28 September 2021 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
1 of 1 declaration
Taunia Markvicka is the Chief Operating Officer of Statera Biopharma, Inc. She oversees the company's operations, ensuring efficiency and process optimization. Her role is essential in supporting Statera's strategic objectives.